Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia B, Congenital”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05365217
What this trial is testing

A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B

Who this might be right for
Haemophilia B
Novo Nordisk A/S 30
Testing effectiveness (Phase 2)Looking for participantsNCT06379789
What this trial is testing

Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Who this might be right for
Hemophilia B
Regeneron Pharmaceuticals 130
Large-scale testing (Phase 3)Looking for participantsNCT07285460
What this trial is testing

Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

Who this might be right for
Hemophilia
Sanofi 85
Large-scale testing (Phase 3)Study completedNCT01425723
What this trial is testing

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

Who this might be right for
Severe Hemophilia B
Bioverativ Therapeutics Inc. 120
Not applicableStudy completedNCT03818529
What this trial is testing

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Who this might be right for
HemophiliaHemophilia AHemophilia B+5 more
American Thrombosis and Hemostasis Network 237
Large-scale testing (Phase 3)Study completedNCT01178294
What this trial is testing

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A

Who this might be right for
Acquired Hemophilia A
Baxalta now part of Shire 29
Testing effectiveness (Phase 2)Ended earlyNCT05789537
What this trial is testing

SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors

Who this might be right for
Hemophilia B with InhibitorHemophilia B
ApcinteX Ltd 3
Post-approval studies (Phase 4)Study completedNCT00581126
What this trial is testing

Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 14
Large-scale testing (Phase 3)Study completedNCT01333111
What this trial is testing

Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 74
Testing effectiveness (Phase 2)Ended earlyNCT06611436
What this trial is testing

BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B

Who this might be right for
Hemophilia BHemophilia B, Moderately Severe or Severe
Be Biopharma 5
Not applicableUnknownNCT03287999
What this trial is testing

Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B

Who this might be right for
Haemophilia
Royal Free Hospital NHS Foundation Trust 250
Not applicableStudy completedNCT00195221
What this trial is testing

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Who this might be right for
Hemophilia BAllergic Reactions
Wyeth is now a wholly owned subsidiary of Pfizer 166
Not applicableStudy completedNCT03901755
What this trial is testing

An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B

Who this might be right for
Hemophilia B
Swedish Orphan Biovitrum 151
Not applicableStudy completedNCT00835068
What this trial is testing

Post Marketing Observational Study of Reformulated BeneFIX

Who this might be right for
Hemophilia B
Pfizer 58
Testing effectiveness (Phase 2)UnknownNCT02463591
What this trial is testing

Reversal of Dabigatran With Prothrombin Complex Concentrate

Who this might be right for
Drug Action Reversal
University Medical Center Groningen 12
Not applicableStudy completedNCT05804734
What this trial is testing

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia

Who this might be right for
Hemophilia AHemophilia BAnticoagulant-induced Bleeding
Groupe Maladies hémorragiques de Bretagne 54
Not applicableWithdrawnNCT02429453
What this trial is testing

FFP Versus PCC in Intracranial Hemorrhage

Who this might be right for
Intracranial Hemorrhage, TraumaticIntracranial Hemorrhage, Spontaneous
University of Utah
Early research (Phase 1)Study completedNCT02571569
What this trial is testing

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 32
Not applicableStudy completedNCT02937831
What this trial is testing

RIXUBIS Drug Use-Result Survey (Japan)

Who this might be right for
Hemophilia B
Baxalta now part of Shire 6
Large-scale testing (Phase 3)Study completedNCT00093171
What this trial is testing

Study Evaluating rFIX; BeneFIX® in Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 23
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation